Butylscopolamine Bromide is an orally available bromide salt form of butylscopolamine, a quaternary ammonium derivative of the alkaloid scopolamine, with anticholinergic property. Upon oral administration, hyoscine butylbromide binds to and blocks muscarinic receptors located on postganglionic parasympathetic nerve endings and on smooth muscle cells. This blocks the activity of acetylcholine (Ach) and causes its antispasmodic effect in the gastrointestinal (GI), urinary, uterine, and biliary tracts. This agent may also facilitate radiologic visualization of the GI tract. It is grouped under the following drug class(es): Anticholinergics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include (9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02, 4]nonan-7-yl) (2S)-3-hydroxy-2-phenylpropanoate;bromide, (-)-Scopolamine, n-Butyl- and bromide. Its PubChem CID is 11957696.
Butylscopolamine bromide
| CAS No | 149-64-4 |
|---|---|
| Molecular Formula | C21H30BrNO4 |
| Molecular Weight | 440.4 g/mol |
| Synonyms | (9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) (2S)-3-hydroxy-2-phenylpropanoate;bromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Butylscopolamine Bromide is an orally available bromide salt form of butylscopolamine, a quaternary ammonium derivative of the alkaloid scopolamine, with anticholinergic property.
The listed CAS number is 149-64-4.
The listed molecular formula is C21H30BrNO4.
The listed molecular weight is 440.4 g/mol.
(9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) (2S)-3-hydroxy-2-phenylpropanoate;bromide.
The source lists (9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02, 4]nonan-7-yl) (2S)-3-hydroxy-2-phenylpropanoate;bromide, (-)-Scopolamine, n-Butyl- and bromide.